（Sr.) Medical Education Manager-Onco at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, HealthcareIndustries

Requirements

Master Degree or above in Medicine
Past clinical and/or industrial experiences in therapeutical area
At least 5 years of clinical experiences and/or industrial experiences in Medical Affairs or other relevant functions
Excellent oral and written communication and interpersonal skills
Medical Affairs launch experience is preferred
Knowledge of principles of adult education and instructional design preferred

Responsibilities

Implement medical education plan in a seamless and timely manner through appropriate involvement of external and internal stakeholders, strong project management, and coordination of resources
Identify specific education needs
Develop the agenda and content of individual education events, identify and manage appropriate speakers
Ensure the conduct of education events aligned with related policies and overall strategy
Ensure deliveries of events on time and with high quality
Ensure the tracking and measurement of each event
Working closely with cross-functional team, identify, engage, and manage suitable TLs in the implementation of medical education activities
Collaborate with cross-functional teams to develop and manage medical society and TPO partnerships on medical education
Ensure medical education programs are fully in compliance with corporate standards and relevant policies

Skills

Medical Education

Project Management

Stakeholder Management

Event Planning

Speaker Engagement

Compliance

Oncology

Medical Affairs

Clinical Experience

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free